Stryker Acquires Inari Medical
Stryker, a global leader in medical technologies, announced that it has completed the acquisition of Inari Medical, Inc., a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs
The addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing VTE segment. “The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We look forward to welcoming the talented Inari team to Stryker and working together to improve outcomes for patients worldwide.” Inari’s product portfolio is highly complementary to Stryker’s Neurovascular business and includes two novel mechanical thrombectomy solutions—the FlowTriever System for the treatment of pulmonary embolism and the ClotTriever System for thrombectomy in the peripheral vessels—as well as emerging therapies.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins